earnings digest health st jude medical results expected to beat estimates st jude medical inc expects to report fourth quarter earnings and revenue above wall street expectations signaling a possible turnaround in the market for its implantable defibrillator device the st paul minn medical device maker said it expects earnings of cents a share compared with the average analyst forecast of cents a share according to thomson financial and sales of about &# million up about from a year earlier and about &# million above analysts average projection the company also expects to report fourth quarter sales of its implantable cardioverter defibrillators or icds were &# million toward the upper end of its earlier forecast of &# million to &# million icds which look like pacemakers and are used to treat dangerously fast heart rates that occur in the lower chambers of the heart are st judes most closely watched product 
